Kangmei Pharmaceutical Co.,Ltd. Posted 111.6 Million Yuan Net Loss in First Quarter of 2022

Kangmei Pharmaceutical Co.,Ltd. (康美药业股份有限公司) (600518.SH) reported a net loss of 111.6 million yuan in the first quarter of 2022, narrowing 81.3% year-on-year.

Meanwhile, the company posted 933.8 million yuan in revenue, down 14.1% year-on-year.

At the end of the reporting period, it had 15.9 billion yuan in total assets and 6.1 billion yuan in total liabilities, with a liability-to-asset ratio of 38.1%.